Brian A. Costello

Mayo Clinic

Papers

1

Total Citations

70

H-Index

1

About

Brian A. Costello is a leading urologic oncologist whose research has fundamentally shaped the surgical management of kidney cancer. His landmark 2012 meta-analysis, “Comparative Effectiveness for Survival and Renal Function of Partial and Radical Nephrectomy for Localized Renal Tumors,” with over 70 citations, provided critical evidence that partial nephrectomy offers equivalent cancer control while better preserving renal function—helping to establish nephron-sparing surgery as the standard of care. Dr. Costello’s work bridges comparative effectiveness research and clinical outcomes, systematically demonstrating the long-term survival and renal benefits of less invasive approaches. Beyond this seminal study, his contributions to urologic oncology have influenced treatment guidelines and improved patient counseling. With a career dedicated to evidence-based surgical decision-making, Dr. Costello continues to advance the field through rigorous outcomes research, ensuring that patients with localized renal tumors receive the most effective, kidney-preserving therapies.

Research Focus

Key Achievements

1
H-Index
1
Papers
70
Total Citations
70
Avg Citations/Paper
🏆 Most Cited Paper
Comparative Effectiveness for Survival and Renal Function of Partial and Radical Nephrectomy for Localized Renal Tumors: A Systematic Review and Meta-Analysis
70 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Mayo Clinic

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago